Brain and induced pluripotent stem cell-derived neural stem cells as an in vitro model of neurodegeneration in ataxia-telangiectasia

Experimental Biology and Medicine

Volumn 238, Issue 3, 2013, Pages 301-307

  Carlessi, Luigi ^a   Poli, Elena Fusar ^a   Delia, Domenico ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Atm; Dna damage; Ips cells; Neural stem cell; Neurodegeneration

Indexed keywords

2 MORPHOLINO 6 (1 THIANTHRENYL) 4 PYRANONE; ATM PROTEIN; BUTHIONINE SULFOXIMINE; MICROTUBULE ASSOCIATED PROTEIN 2; SHORT HAIRPIN RNA;

ATAXIA TELANGIECTASIA; CANCER SUSCEPTIBILITY; CELL DIFFERENTIATION; CELL PROLIFERATION; DNA DAMAGE; DNA REPAIR; EPIGENETICS; IMMUNE DEFICIENCY; NERVE DEGENERATION; NEURAL STEM CELL; NONHUMAN; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; REVIEW; SOMATIC CELL; WESTERN BLOTTING;

ATAXIA TELANGIECTASIA; BRAIN; CELL CYCLE PROTEINS; CELLS, CULTURED; DNA DAMAGE; DNA-BINDING PROTEINS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MODELS, BIOLOGICAL; MYOCARDIUM; NERVE DEGENERATION; NEURAL STEM CELLS; OXIDATION-REDUCTION; PROTEIN-SERINE-THREONINE KINASES; TUMOR SUPPRESSOR PROTEINS;

EID: 84877685731     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/1535370213480703     Document Type: Review

References (37)

1. Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer 2003;3:155-68.
2. McKinnon PJ. ATM and the molecular pathogenesis of Ataxia Telangiectasia. Annu Rev Pathol 2012;7:303-21.
3. Bensimon A, Schmidt A, Ziv Y, Elkon R, Wang SY, Chen DJ, Aebersold R, Shiloh Y. ATM-dependent and -independent dynamics of the nuclear phosphoproteome after DNA damage. Sci Signal 2010;3:rs3.
4. Barzilai A, Rotman G, Shiloh Y. ATM deficiency and oxidative stress: a new dimension of defective response to DNA damage. DNA Repair 2002;1:3-25.
5. Liu N, Stoica G, Yan M, Scofield VL, Qiang W, Lynn WS, Wong PK. ATM deficiency induces oxidative stress and endoplasmic reticulum stress in astrocytes. Lab Invest 2005;85:1471-80.
6. Reliene R, Schiestl RH. Antioxidant N-acetyl cysteine reduces incidence and multiplicity of lymphoma in Atm deficient mice. DNA Repair 2006;5:852-59.
7. Arakawa M, Ushimaru N, Osada N, Oda T, Ishige K, Ito Y. N-acetylcysteine selectively protects cerebellar granule cells from 4-hydroxynonenal-induced cell death. Neurosci Res 2006;55:255-63.
8. Guo Z, Kozlov S, Lavin MF, Person MD, Paull TT. ATM activation by oxidative stress. Science 2010;330:517-21.
9. Yang Y, Herrup K. Loss of neuronal cell cycle control in Ataxia-Telangiectasia: a unified disease mechanism. J Neurosci 2005;25:2522-9.
10. Boehrs JK, He J, Halaby M, Yang D. Constitutive expression and cytoplasmic compartmentalization of ATM protein in differentiated human neuron-like SH-SY5Y cells. J Neurochem 2007;100:337-45.
11. Li J, Han YR, Plummer MR, Herrup K. Cytoplasmic ATM in neurons modulates synaptic function. Curr Biol 2009;19:2091-6.
12. Li J, Chen J, Ricupero CL, Hart RP, Schwartz MS, Kusnecov A, Herrup K. Nuclear accumulation of HDAC4 in ATM deficiency promotes neurodegeneration in ataxia telangiectasia. Nat Med 2012;18:783-90.
13. Barzilai A. The neuro-glial-vascular interrelations in genomic instability symptoms. Mech Ageing Dev 2011;132:395-404.
14. Ferrari D, Zalfa C, Rota Nodari L, Gelati M, Carlessi L, Delia D, Vescovi A, De Filippis L. Differential pathotropism of non-immortalized and immortalized human neural stem cell lines in a focal demyelination model. Cell Mol Life Sci 2012;7:1193-210.
15. Carlessi L, De Filippis L, Lecis D, Vescovi A, Delia D. DNA-damage response, survival and differentiation in vitro of a human neural stem cell line in relation to ATM expression. Cell Death Differ 2009;16:795-806.
16. Pollock K, Stroemer P, Patel S, Stevanato L, Hope A, Miljan E, Dong Z, Hodges H, Price J, Sinden JD. A conditionally immortal clonal stem cell line from human cortical neuroepithelium for the treatment of ischemic stroke. Exp Neurol 2006;199:143-55.
17. Donato R, Miljan EA, Hines SJ, Aouabdi S, Pollock K, Patel S, Edwards FA, Sinden JD. Differential development of neuronal physiological responsiveness in two human neural stem cell lines. BMC Neurosci 2007;8:36.
18. De Filippis L, Lamorte G, Snyder EY, Malgaroli A, Vescovi AL. A novel, immortal, and multipotent human neural stem cell line generating functional neurons and oligodendrocytes. Stem Cells 2007;25:2312-21.
19. Hitomi M, Stacey DW. The checkpoint kinase ATM protects against stress-induced elevation of cyclin D1 and potential cell death in neurons. Cytometry Part A 2010;77A:524-33.
20. Biton S, Gropp M, Itsykson P, Pereg Y, Mittelman L, Johe K, Reubinoff B, Shiloh Y. ATM-mediated response to DNA double strand breaks in human neurons derived from stem cells. DNA Repair 2007;6:128-34.
21. Coufal NG, Garcia-Perez J, Peng GE, Marchetto MCN, Muotri AR, Mu Y, Carson CT, Macia A, Moran JV, Gage FH. Ataxia telangiectasia mutated (ATM) modulates long interspersed element-1 (L1) retrotransposition in human neural stem cells. Proc Natl Acad Sci 2011;108:20382-7.
22. Adams BR, Golding SE, Rao RR, Valerie K. Dynamic dependence on ATR and ATM for double-strand break repair in human embryonic stem cells andneural descendants. PLoS ONE 2010;5:e10001.
23. Stewart R, Kozlov S, Gatei M, Kijas AW, Mackay-Sim A, Lavin M. A cellular model to investigate the role of ATM in the nervous system. ATW 2012, 148 International Workshop on Ataxia-Telangiectasia, New Delhi, India 2012.
24. Carlessi L, Fusar Poli E, De Filippis L, Delia D. ATM-deficient human neural stem cells as an in vitro model system to study neurodegeneration. DNA Repair 2013 in press
25. Nayler S, Gatei M, Kozlov S, Gatti R, Mar JC, Wells CA, Lavin M, Wolvetang E. Induced pluripotent stem cells from Ataxia-Telangiectasia recapitulate the cellular phenotype. Stem Cells Transl Med 2012;1:523-35.
26. McKinnon PJ. DNA repair deficiency and neurological disease. Nat Rev Neurosci 2009;10:100-12.
27. Biton S, Dar I, Mittelman L, Pereg Y, Barzilai A, Shiloh Y. Nuclear Ataxia-Telangiectasia Mutated (ATM) mediates the cellular response to DNA double strand breaks in human neuron-like cells. J Biol Chem 2006;281:17482-91.
28. Lee DH, Goodarzi AA, Adelmant GO, Pan Y, Jeggo PA, Marto JA, Chowdhury D. Phosphoproteomic analysis reveals that PP4 dephosphorylates KAP-1 impacting the DNA damage response. EMBO Journal 2012;31:2403-15.
29. Fernando RN, Eleuteri B, Abdelhady S, Nussenzweig A, Andang M, Ernfors P. Cell cycle restriction by histone H2AX limits proliferation of adult neural stem cells. Proc Natl Acad Sci USA 2011;108:5837-42.
30. Andang M, Hjerling-Leffler J, Moliner A, Lundgren TK, Castelo-Branco G, Nanou E, Pozas E, Bryja V, Halliez S, Nishimaru H, Wilbertz J, Arenas E, Koltzenburg M, Charnay P, El Manira A, Ibanez CF, Ernfors P. Histone H2AX-dependent GABA(A) receptor regulation of stem cell proliferation. Nature 2008;451:460-4.
31. Perry TL, Kish SJ, Hinton D, Hansen S, Becker LE, Gelfand EW. Neurochemical abnormalities in a patient with ataxia-telangiectasia. Neurology 1984;34:187-91.
32. Gazulla J, Benavente I, Sarasa Barrio M. Adult-onset ataxia-telangiectasia. A clinical and therapeutic observation. Neurologia 2006;21:447-51.
33. Santilli G, Lamorte G, Carlessi L, Ferrari D, Nodari LR, Binda E, Delia D, Vescovi AL, De Filippis L. Mild hypoxia enhances proliferation and multipotency of human neural stem cells. PLoS ONE 2010;5:e8575.
34. Xiong H, Xia K, Li B, Zhao G, Zhang Z. KChIP1: a potential modulator to GABAergic system. Acta Biochim Biophys Sin (Shanghai) 2009;41:295-300.
35. Xu Y, Ashley T, Brainerd EE, Bronson RT, Meyn MS, Baltimore D. Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma. Genes Dev 1996;10:2411-22.
36. Herzog KH, Chong MJ, Kapsetaki M, Morgan JI, McKinnon PJ. Requirement for Atm in ionizing radiation-induced cell death in the developing central nervous system. Science 1998;280:1089-91.
37. Jakel RJ, Schneider BL, Svendsen CN. Using human neural stem cells to model neurological disease. Nat Rev Genet 2004;5:136-44